EDITORIALS

2022, a new dawn for the biocluster


Stephane Beaudet


Year 2022 laid the foundations for a new chapter in Genopole's history, ushering in solid, stable and collegial management with Genopole's GIP and SEM entities. This new chapter is being written in coherence with the ambitions of the French Nation, as expressed in the France 2030 plan, and those of the Île-de-France Administrative Region, with its Impact 2028 plan for economic development, innovation and internationalization.

A dynamic of reinvention

France needs cutting-edge laboratories and innovative start-ups to meet its goals in health security & independence, industrial relocalization, and decarbonization & the green economy transition.

The academic laboratories and biotech businesses that Genopole accompanies are busy inventing new ways to empower manufacturing, healthcare, farming, nutrition, mobility and more. Genopole itself is focused on inventing new tools and spaces to support their creativity.

Thereto, the biocluster benefits from the continuing support of the French Ministry of Higher Education and Research, as reiterated by Minister Sylvie Retailleau, whom we had the pleasure of welcoming at Genopole in November. We thank her again for her mobilization to boost the GIP during her presidency of Paris-Saclay University. The arrival of Gilles Trystram at the helm of the GIP has accelerated this dynamic. I was pleased to accompany Paris-Saclay University President Estelle Iacona in numerous exchanges with the Saclay hub, exchanges that will result in concrete and collective initiatives to strengthen the territory's excellence in academic research in 2023.

From innovation to production

To convert this enormous research and innovation potential into production potential, Genopole has developed an ambitious real estate strategy to be deployed in 2023. It involves several construction programs under the guidance of SEM teams headed by David Bodet. The careful consideration of feedback from Genopole's accompanied businesses, who notably confront challenges related to premises, enabled a change of Évry-Courcouronnes's urban land use plans (in association with Grand Paris Sud) to ease the construction of large industrial facilities, which will bring recognition to Genopole as a site for biomanufacturing in France.

I would like to express my thanks to Chief Executive Gilles Trystram, Deputy Director David Bodet and all of the involved teams for this outstanding work done in 2022 to bring a new dynamic to Genopole. I also thank our founding members and partners, the French State, the Île-de-France Administrative Region, the Essonne Administrative Department, the Grand Paris Sud Urban Area, the AFM-Téléthon and the Essonne Prefecture, all steadfast allies lending their support to enable our ambitions.

Stéphane Beaudet, President of Genopole